Pharvaris
Pharvaris is a late-stage biopharmaceutical company developing novel oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases, with a focus on hereditary angioedema and other unmet patient needs.
Build your career on Magnet.me
Create a profile and receive connection requests from interested companies.
Jobs
Interesting to know
This company page was generated automatically and therefore features only limited information. Find out more about Pharvaris on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about Pharvaris on their company website: